Stephen J. Tulipano, Chief Financial Officer at Aldeyra Therapeutics, Inc. (ALDX), bought 3,333 shares at $4.50 ($15K) on 2017-02-17, disclosed to the SEC on 2017-02-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| STOK | SELL | 2020-11-04 | $5.4M | — | Filing → |
| JAV | SELL | 2010-05-05 | $5K | — | Filing → |